Safety, Tolerability and PK Study of Single Doses of ABT-450 With and Without Ritonavir to Treat Hepatitis C Virus (HCV) Genotype 1

NCT00850044 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

87

Enrollment

INDUSTRY

Sponsor class

Conditions

HCV Infection

Interventions

DRUG: ABT-450
DRUG: ritonavir
DRUG: placebo for ABT-450
DRUG: Placebo for ritonavir

Sponsor

AbbVie